# Brainsway Ltd.: financial statements, quarterly

BWAY · Nasdaq · CIK 1505065 · [Healthcare](/sectors/healthcare.md)

Pages: [Overview](/companies/bway.md) · [Financials](/companies/bway/financials.md) · [Filings](/companies/bway/filings.md) · [Insiders](/companies/bway/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bway/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2016-12-31) | period not labelled (2017-12-31) | period not labelled (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [9.2](/filings/0001213900-20-007056.md) | [14.5](/filings/0001171843-21-002565.md) | [9.0](/filings/0001171843-22-002539.md) | [21.7](/filings/0001171843-23-001915.md) | [17.0](/filings/0001171843-24-001696.md) | [16.9](/filings/0001171843-25-002347.md) | [47.6](/filings/0001171843-25-002347.md) | [10.5](/filings/0001171843-25-002347.md) | [69.3](/filings/0001171843-25-002347.md) |
| Current assets | $m | not reported | not reported | [13.5](/filings/0001213900-20-007056.md) | [28.8](/filings/0001171843-21-002565.md) | [24.3](/filings/0001171843-22-002539.md) | [65.4](/filings/0001171843-23-001915.md) | [58.1](/filings/0001171843-24-001696.md) | [55.5](/filings/0001171843-25-002347.md) | [79.7](/filings/0001171843-25-002347.md) |
| Total assets | $m | not reported | not reported | [23.6](/filings/0001213900-20-007056.md) | [38.7](/filings/0001171843-21-002565.md) | [34.0](/filings/0001171843-22-002539.md) | [75.7](/filings/0001171843-23-001915.md) | [64.5](/filings/0001171843-24-001696.md) | [63.0](/filings/0001171843-25-002347.md) | [94.3](/filings/0001171843-25-002347.md) |
| Current liabilities | $m | not reported | not reported | [8.3](/filings/0001213900-20-007056.md) | [6.7](/filings/0001171843-21-002565.md) | [6.8](/filings/0001171843-22-002539.md) | [9.1](/filings/0001171843-23-001915.md) | [8.1](/filings/0001171843-24-001696.md) | [9.8](/filings/0001171843-25-002347.md) | [15.3](/filings/0001171843-25-002347.md) |
| Shareholders' equity | $m | [10.3](/filings/0001213900-20-007056.md) | [12.7](/filings/0001171843-21-002565.md) | [7.0](/filings/0001171843-22-002539.md) | [24.2](/filings/0001171843-23-001915.md) | [19.6](/filings/0001171843-24-001696.md) | [57.3](/filings/0001171843-25-002347.md) | [45.4](/filings/0001171843-25-002347.md) | [41.6](/filings/0001171843-25-002347.md) | [62.3](/filings/0001171843-25-002347.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Shareholders' equity: ifrs-full:Equity

Shares outstanding: 39,165,806 at 2025-12-31, from the cover of the [20-F filed 2026-04-20](/filings/0001171843-26-002568.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.